Opens in a new tab
Home/Investor Relations

Investor Relations

2015founded at RWTH Aachen University
ISO 9001:2015certified by TÜV Rheinland
ELAREM™patented Human Platelet Lysate platform
Aachen, DEheadquarters and production

PL BioScience is supporting trailblazing cell-based research and manufacturing. Let us work together on this journey.

Backed by
Milestones

How we got here

2015Founded & first funded

Spun out of RWTH Aachen University. Awarded the EXIST Business Start-up Grant by the German Federal Ministry for Economic Affairs and Energy.

PlatformELAREM™ consolidated

The Human Platelet Lysate portfolio was consolidated under the patented ELAREM™ Platform brand.

Scale-upScale-up.NRW, batch #4

Joined the Scale-up.NRW programme — the step from early-stage venture toward an established supply partner.

QualityISO 9001:2015 certified

Quality management certified by TÜV Rheinland — the backbone for consistent, clinic-ready batch supply.

PL BioScience management
Investor contact

Talk to management directly

For investment, partnering or licensing enquiries, get in touch with the management team — we respond personally.

Contact us →